Two overlapping subtypes, triple negative (TN) breast cancer lacking estrogen receptor (ER), progesterone receptor (PR), and Her2 receptors, and basal-like breast cancer, which is generally associated with BRCA1 activation, are normally more aggressive and have poorer prognoses (124). The gene discussed is ESR1; the disease is breast carcinoma.